A carregar...
Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
BACKGROUND: Cancer patients are at increased risk for venous thromboembolism (VTE) due to cancer-induced hypercoagulability. However, current guidelines do not routinely recommend prophylactic use of oral anticoagulants to prevent VTE in cancer patients. OBJECTIVE: To evaluate the efficacy and safet...
Na minha lista:
| Publicado no: | Risk Manag Healthc Policy |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114826/ https://ncbi.nlm.nih.gov/pubmed/33994816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RMHP.S306760 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|